MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer.

MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer.

OBJECTIVE: Triple-negative breast cancer (TNBC) patients with truly chemosensitive disease still represent a minority among all TNBC patients. The aim of the present study is to identify microRNAs (miRNAs) that correlate with TNBC chemoresistance. METHODS: In this study, we conducted miRNAs profile...

Full description

Bibliographic Details
Main Authors:	Mao Ouyang, Yongxin Li, Sheng Ye, Jieyi Ma, Liming Lu, Weiming Lv, Guangqi Chang, Xiaoxi Li, Qing Li, Shenming Wang, Wenjian Wang
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4008525?pdf=render

Similar Items

MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma.
by: Sameer A Dhayat, et al.
Published: (2015-01-01)

Hijacking 5-Fluorouracil Chemoresistance in Triple Negative Breast Cancer via microRNAs-Loaded Chitosan Nanoparticles
by: Sherif Ashraf Fahmy, et al.
Published: (2024-02-01)

DSTYK Enhances Chemoresistance in Triple-Negative Breast Cancer Cells
by: Stella C. Ogbu, et al.
Published: (2021-12-01)

CHFR regulates chemoresistance in triple-negative breast cancer through destabilizing ZEB1
by: Hong Luo, et al.
Published: (2021-08-01)

RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells via activating MMP1
by: Wentao Si, et al.
Published: (2022-11-01)

KIF14 Promotes AKT Phosphorylation and Contributes to Chemoresistance in Triple-Negative Breast Cancer
by: Stina M. Singel, et al.
Published: (2014-03-01)

The WAVE3/β-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer
by: Wei Wang, et al.
Published: (2023-03-01)

HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk
by: Hengyu Li, et al.
Published: (2022-01-01)

The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer
by: Lin He, et al.
Published: (2021-12-01)

The Prognostic and Therapeutic Implications of the Chemoresistance Gene BIRC5 in Triple-Negative Breast Cancer
by: Getinet M. Adinew, et al.
Published: (2022-10-01)

Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies
by: Anindita Chakrabarty, et al.
Published: (2021-06-01)

Co-Targeting IGF-1R and Autophagy Enhances the Effects of Cell Growth Suppression and Apoptosis Induced by the IGF-1R Inhibitor NVP-AEW541 in Triple-Negative Breast Cancer Cells.
by: Weibin Wu, et al.
Published: (2017-01-01)

High Expression of RAI14 in Triple-Negative Breast Cancer Participates in Immune Recruitment and Implies Poor Prognosis Through Bioinformatics Analyses
by: Ranliang Cui, et al.
Published: (2022-04-01)

Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells
by: Lisa Agnello, et al.
Published: (2023-07-01)

Omics Analysis of Chemoresistant Triple Negative Breast Cancer Cells Reveals Novel Metabolic Vulnerabilities
by: Dimitris Kordias, et al.
Published: (2022-08-01)

Deptor Enhances Triple-Negative Breast Cancer Metastasis and Chemoresistance through Coupling to Survivin Expression
by: Jenny G. Parvani, et al.
Published: (2015-03-01)

MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance
by: Dawid Mehlich, et al.
Published: (2021-11-01)

MicroRNA-based chemoresistance in glioblastoma
by: Zhenghui Ma, et al.
Published: (2019-01-01)

Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer
by: Shen-Jun Yuan, et al.
Published: (2019-10-01)

TRAF6 promotes chemoresistance to paclitaxel of triple negative breast cancer via regulating PKM2‐mediated glycolysis
by: Han Xu, et al.
Published: (2023-10-01)

The Oxygen-Generating Calcium Peroxide-Modified Magnetic Nanoparticles Attenuate Hypoxia-Induced Chemoresistance in Triple-Negative Breast Cancer
by: Fong-Yu Cheng, et al.
Published: (2021-02-01)

Periostin drives extracellular matrix degradation, stemness, and chemoresistance by activating the MAPK/ERK signaling pathway in triple–negative breast cancer cells
by: Jinna Wu, et al.
Published: (2023-09-01)

USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1
by: Yueh-Te Lin, et al.
Published: (2022-10-01)

Tumor-initiating CD49f cells are a hallmark of chemoresistant triple negative breast cancer
by: Jorge Gomez-Miragaya, et al.
Published: (2017-07-01)

CXCR2 Small-Molecule Antagonist Combats Chemoresistance and Enhances Immunotherapy in Triple-Negative Breast Cancer
by: Alaa M. Ghallab, et al.
Published: (2022-04-01)

ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple‐negative breast cancer models
by: Emma Polonio‐Alcalá, et al.
Published: (2022-06-01)

microRNAs in cancer chemoresistance: The sword and the shield
by: Priya Mondal, et al.
Published: (2021-12-01)

M6A demethylase ALKBH5 regulates FOXO1 mRNA stability and chemoresistance in triple-negative breast cancer
by: Xi Liu, et al.
Published: (2024-02-01)

MicroRNA-based potential diagnostic, prognostic and therapeutic applications in triple-negative breast cancer
by: Qian Tang, et al.
Published: (2019-12-01)

A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer
by: Sambi M, et al.
Published: (2020-05-01)

miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A
by: Liu C, et al.
Published: (2020-12-01)

Short-term curative effect of endovascular stent-graft treatment for aortic diseases in China: a systematic review.
by: Siwen Wang, et al.
Published: (2013-01-01)

CENPF knockdown inhibits adriamycin chemoresistance in triple-negative breast cancer via the Rb-E2F1 axis
by: Depeng Wang, et al.
Published: (2023-01-01)

MicroRNAs expression in triple negative vs non triple negative breast cancer in Tunisia: interaction with clinical outcome.
by: Imen Medimegh, et al.
Published: (2014-01-01)

MicroRNAs: an emerging paradigm in lung cancer chemoresistance
by: Srivatsava eNaidu, et al.
Published: (2015-11-01)

High Expression of microRNA-223 Indicates a Good Prognosis in Triple-Negative Breast Cancer
by: Li Chen, et al.
Published: (2021-04-01)

CYP1B1 Augments the Mesenchymal, Claudin-Low, and Chemoresistant Phenotypes of Triple-Negative Breast Cancer Cells
by: Paul R. Hollis, et al.
Published: (2022-08-01)

β-Caryophyllene Counteracts Chemoresistance Induced by Cigarette Smoke in Triple-Negative Breast Cancer MDA-MB-468 Cells
by: Antonella Di Sotto, et al.
Published: (2022-09-01)

DAB2IP attenuates chemoresistance of triple‐negative breast cancer through sequestration of RAC1 to prevent β‐catenin nuclear accumulation
by: Zhenchong Xiong, et al.
Published: (2022-12-01)

MicroRNA-454 may function as an oncogene via targeting AKT in triple negative breast cancer
by: Qun Li, et al.
Published: (2017-08-01)